Evidence map›Paper›PMID 37820738›Full record

ArticleThe Journal of infectious diseases2024

Sexual Exposures Associated With Mpox Infection: California, November 2022 to June 2023.

Robert E Snyder, Kayla Saadeh, Eric C Tang, Kelly A Johnson, Samuel N Holland, Joshua Quint, Nicole O Burghardt, Shua J Chai, Roshani Fernando, Kimberly Gonzalez Barrera and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Robert E SnyderSexually Transmitted Diseases Control Branch, California Department of Public Health, Richmond and Sacramento, California, USA.
Kayla SaadehSexually Transmitted Diseases Control Branch, California Department of Public Health, Richmond and Sacramento, California, USA.
Eric C TangSexually Transmitted Diseases Control Branch, California Department of Public Health, Richmond and Sacramento, California, USA.
Kelly A JohnsonSexually Transmitted Diseases Control Branch, California Department of Public Health, Richmond and Sacramento, California, USA.
Samuel N HollandSexually Transmitted Diseases Control Branch, California Department of Public Health, Richmond and Sacramento, California, USA.
Joshua QuintSexually Transmitted Diseases Control Branch, California Department of Public Health, Richmond and Sacramento, California, USA.
Nicole O BurghardtSexually Transmitted Diseases Control Branch, California Department of Public Health, Richmond and Sacramento, California, USA.
Shua J ChaiSexually Transmitted Diseases Control Branch, California Department of Public Health, Richmond and Sacramento, California, USA.
Roshani FernandoSexually Transmitted Diseases Control Branch, California Department of Public Health, Richmond and Sacramento, California, USA.
Kimberly Gonzalez BarreraSexually Transmitted Diseases Control Branch, California Department of Public Health, Richmond and Sacramento, California, USA.
Cindy HernandezSexually Transmitted Diseases Control Branch, California Department of Public Health, Richmond and Sacramento, California, USA.
Korie McManusSexually Transmitted Diseases Control Branch, California Department of Public Health, Richmond and Sacramento, California, USA.
Kieran LorenzSexually Transmitted Diseases Control Branch, California Department of Public Health, Richmond and Sacramento, California, USA.
Jarett MaycottSexually Transmitted Diseases Control Branch, California Department of Public Health, Richmond and Sacramento, California, USA.
John McGinleySexually Transmitted Diseases Control Branch, California Department of Public Health, Richmond and Sacramento, California, USA.
Joseph A LewnardSchool of Public Health, University of California, Berkeley, California, USA.
California Department of Public Health · USUniversity of California, Berkeley · USOffice of Readiness and Response · US

Funding

National Institute of Allergy and Infectious Diseases R01-AI14812701US Centers for Disease Control and Prevention PS19-1901
6 · The paper itself

Abstract

backgroundExposures associated with mpox infection remain imperfectly understood.

methodsWe conducted a case-control study enrolling participants who received molecular tests for mpox/orthopoxvirus in California from November 2022 through June 2023. We collected data on behaviors during a 21-day risk period before symptom onset or testing among mpox case patients and test-negative controls.

resultsThirteen of 54 case patients (24.1%) and 5 of 117 controls (4.3%) reported sexual exposure to individuals they identified as potential mpox case patients ("index contacts"; odds ratio [OR], 7.7 [95% confidence interval (CI), 2.5-19.3] relative to individuals who did not report exposure to potential mpox case patients). Among these participants, 10 of 13 case patients (76.9%) and 2 of 5 controls (40.0%) reported that their index contacts were not experiencing symptoms visible to participants during sex (OR, 14.9 [95% CI, 3.6-101.8]). Only 3 of 54 case patients (5.6%) reported exposure to symptomatic index contacts. Case patients reported more anal/vaginal sex partners than did controls (adjusted OR, 2.2 [95% CI, 1.0-4.8] for 2-3 partners and 3.8 [1.7-8.8] for ≥4 partners). Male case patients with penile lesions more commonly reported insertive anal/vaginal sex than those without penile lesions (adjusted OR, 9.3 [95% CI, 1.6-54.8]). Case patients with anorectal lesions more commonly reported receptive anal sex than those without anorectal lesions (adjusted OR, 14.4 [95% CI, 1.0-207.3]).

conclusionsSexual exposure to contacts known or suspected to have experienced mpox was associated with increased risk of infection, often when index contacts lacked apparent symptoms. Exposure to more sex partners, including those whom participants did not identify as index contacts, was associated with increased risk of infection in a site-specific manner. While participants' assessment of symptoms in partners may be imperfect, these findings suggest that individuals without visibly prominent mpox symptoms transmit infection.

Indexed as

HIV InfectionsMpox, MonkeypoxSexual and Gender MinoritiesCaliforniaCase-Control StudiesFemaleHomosexuality, MaleHumansMaleRisk FactorsSexual Behavior

Identifiers

PMID37820738
PMCPMC10965208
OpenAlexW4387563660

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.